Alison V. Crum
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alison V. Crum has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Bradley J. Katz
Department of Ophthalmology and Visual Sciences, John A Moran Eye Center, University of Utah Health, Salt Lake City, UT, USA
2 shared publications - Judith E. A. Warner
Moran Eye Center, University of Utah, Salt lake City, Utah
2 shared publications - Kathleen B. Digre
University of Utah
2 shared publications - Aileen G. MacLachlan
University of Utah (AGM, CMC, MDS), Spencer F. Eccles School of Medicine, Salt Lake City, Utah; University of Utah (NKM), Salt Lake City, Utah; Department of Ophthalmology and Visual Sciences (AVC, KBD, BJK, SV, JEAW, TML, MDS), John A. Moran Eye Center, University of Utah, Salt Lake City, Utah; and Department of Neurology (AVC, KBD, BJK, SV, JEAW, MDS), University of Utah, Salt Lake City, Utah
1 shared publication - Cameron M. Carpenter1 shared publication
- Chong Zhang
Division of Epidemiology, Department of Medicine, University of Utah, Salt Lake City, Utah
1 shared publication
Latest Publications
- 23 September 2026
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 46 (4) , 515-520
Use of a Virtual Reality Visual Field Device to Improve Quality of Care in the Emergency Department and Inpatient Setting
Background: Automated visual field testing is an essential diagnostic and disease monitoring tool for many neuro-ophthalmic disorders. Most commonly, automated devices are stationary and located in ophthalmology clinics. Thus, formal visual field testing has been limited in the hospital setting until recent availability of virtual reality visual field testing. In this study, we report our experience with the use of a virtual visual field (VVF) device in the Emergency Department (ED) and inpatient hospital settings. Methods: We performed a retrospective chart review of our use of a VVF device in the ED and inpatient hospital setting from February 2020 to September 2022. We report our experience and the impact on patient care with use of the VVF device. Results: One hundred fifty patients (aged 10–85 years) and 162 visual field encounters were identified. Patients were most commonly located on the regular hospital ward (51%), followed by the intensive care unit (28%), and ED (21%). The VVF prevented the need for a trip to the outpatient ophthalmology clinic in 100% of encounters of patients with vision-threatening papilledema. Use of the VVF provided a more detailed, baseline examination at bedside in 61% of all encounters. A bedside pre- and postoperative visual field assessment was achieved in 14% of encounters. The VVF changed management in 70% of encounters. Conclusions: In our experience, use of the VVF has improved the quality of care for inpatients with neuro-ophthalmic conditions. A significant impact of the VVF was increased safety by preventing the need to transport patients to the outpatient setting for visual field monitoring, especially patients with vision-threatening papilledema and lumbar drains. The VVF made formal visual testing available to patients with mobility restrictions and patients undergoing neurosurgical procedures. Owing to improvement in quality of patient care, the VVF analyzer has become a mainstay of the examination of patients in the ED and hospital.
- 23 September 2026
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 46 (4) , 515-520
Use of a Virtual Reality Visual Field Device to Improve Quality of Care in the Emergency Department and Inpatient Setting
Background: Automated visual field testing is an essential diagnostic and disease monitoring tool for many neuro-ophthalmic disorders. Most commonly, automated devices are stationary and located in ophthalmology clinics. Thus, formal visual field testing has been limited in the hospital setting until recent availability of virtual reality visual field testing. In this study, we report our experience with the use of a virtual visual field (VVF) device in the Emergency Department (ED) and inpatient hospital settings. Methods: We performed a retrospective chart review of our use of a VVF device in the ED and inpatient hospital setting from February 2020 to September 2022. We report our experience and the impact on patient care with use of the VVF device. Results: One hundred fifty patients (aged 10–85 years) and 162 visual field encounters were identified. Patients were most commonly located on the regular hospital ward (51%), followed by the intensive care unit (28%), and ED (21%). The VVF prevented the need for a trip to the outpatient ophthalmology clinic in 100% of encounters of patients with vision-threatening papilledema. Use of the VVF provided a more detailed, baseline examination at bedside in 61% of all encounters. A bedside pre- and postoperative visual field assessment was achieved in 14% of encounters. The VVF changed management in 70% of encounters. Conclusions: In our experience, use of the VVF has improved the quality of care for inpatients with neuro-ophthalmic conditions. A significant impact of the VVF was increased safety by preventing the need to transport patients to the outpatient setting for visual field monitoring, especially patients with vision-threatening papilledema and lumbar drains. The VVF made formal visual testing available to patients with mobility restrictions and patients undergoing neurosurgical procedures. Owing to improvement in quality of patient care, the VVF analyzer has become a mainstay of the examination of patients in the ED and hospital.
- 5 August 2020
- Published by Springer Nature
- p. 279-293
Congenital Ptosis
- 5 August 2020
- Published by Springer Nature
- p. 231-239
Ocular Cicatricial Pemphigoid
- Open Access
- 1 April 2017
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 5, 111-113
Shingles as the underlying cause of orbital myositis in an adolescent: A case report
- 1 April 2017
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 5, 111-113
Open AccessShingles as the underlying cause of orbital myositis in an adolescent: A case report
- Open Access
- 14 April 2016
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 17 (1) , 1-7
Increased prevalence of depression and anxiety in patients with migraine and interictal photophobia
Most patients with migraine report photophobia associated with headache; a subset report interictal photophobia. These patients are light sensitive even during headache-free periods. The objective of this case–control study was to assess the prevalence of symptoms of anxiety and depression in migraine patients with and without interictal photophobia. We recruited 16 subjects with migraine and interictal photophobia, 16 age- and gender-matched migraine subjects without interictal photophobia, and 16 age- and gender- matched controls. Migraine subjects met International Headache Society classification criteria. Participants completed a photophobia questionnaire, Beck Depression Inventory (BDI-II), and Beck Anxiety Inventory (BAI). Chi-square analyses and two-tailed Wilcoxon rank sum tests were used for the analyses. Subjects with interictal photophobia had significantly higher scores on the photophobia questionnaire compared to subjects without interictal photophobia. Subjects with interictal photophobia had significantly higher scores on the BDI-II and BAI compared to subjects without interictal photophobia. Migraine patients with interictal photophobia are more likely to manifest symptoms of depression and anxiety compared to migraine patients without interictal photophobia. Care providers should be aware of increased prevalence of these symptoms in this population and consider appropriate referrals. Future research could assess whether treatment of photophobia leads to improvements in symptoms of depression and anxiety in migraine patients.
- 14 April 2016
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 17 (1) , 1-7
Open AccessIncreased prevalence of depression and anxiety in patients with migraine and interictal photophobia
Most patients with migraine report photophobia associated with headache; a subset report interictal photophobia. These patients are light sensitive even during headache-free periods. The objective of this case–control study was to assess the prevalence of symptoms of anxiety and depression in migraine patients with and without interictal photophobia. We recruited 16 subjects with migraine and interictal photophobia, 16 age- and gender-matched migraine subjects without interictal photophobia, and 16 age- and gender- matched controls. Migraine subjects met International Headache Society classification criteria. Participants completed a photophobia questionnaire, Beck Depression Inventory (BDI-II), and Beck Anxiety Inventory (BAI). Chi-square analyses and two-tailed Wilcoxon rank sum tests were used for the analyses. Subjects with interictal photophobia had significantly higher scores on the photophobia questionnaire compared to subjects without interictal photophobia. Subjects with interictal photophobia had significantly higher scores on the BDI-II and BAI compared to subjects without interictal photophobia. Migraine patients with interictal photophobia are more likely to manifest symptoms of depression and anxiety compared to migraine patients without interictal photophobia. Care providers should be aware of increased prevalence of these symptoms in this population and consider appropriate referrals. Future research could assess whether treatment of photophobia leads to improvements in symptoms of depression and anxiety in migraine patients.